Trademark: 88373385
Status Date
Tuesday, June 15, 2021
Registration Number
6389841
Registration Date
Tuesday, June 15, 2021
Filing Date
Friday, April 5, 2019
Published for Opposition
Tuesday, July 9, 2019
42 Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes
Color is not claimed as a feature of the mark.
The mark consists of a circle containing the stylized image of a woman looking into a microscope.
Jun 15, 2021
Registered-Principal Register
May 14, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
May 13, 2021
Allowed Principal Register - Sou Accepted
May 13, 2021
Examiner's Amendment Entered
May 13, 2021
Notification Of Examiners Amendment E-Mailed
May 13, 2021
Examiners Amendment E-Mailed
May 13, 2021
Su-Examiner's Amendment Written
Jan 29, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 29, 2021
Teas Change Of Correspondence Received
Jan 29, 2021
Teas Change Of Owner Address Received
Oct 29, 2020
Notification Of Final Refusal Emailed
Oct 29, 2020
Final Refusal E-Mailed
Oct 29, 2020
Su - Final Refusal - Written
Oct 6, 2020
Teas/Email Correspondence Entered
Oct 6, 2020
Correspondence Received In Law Office
Oct 6, 2020
Assigned To Lie
Sep 21, 2020
Teas Response To Office Action Received
Sep 11, 2020
Notification Of Non-Final Action E-Mailed
Sep 11, 2020
Non-Final Action E-Mailed
Sep 11, 2020
Su - Non-Final Action - Written
Aug 13, 2020
Statement Of Use Processing Complete
Aug 3, 2020
Use Amendment Filed
Aug 13, 2020
Case Assigned To Intent To Use Paralegal
Aug 3, 2020
Teas Statement Of Use Received
Jul 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 8, 2020
Teas Change Of Correspondence Received
Jul 8, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 8, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2020
Teas Change Of Owner Address Received
Mar 5, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 3, 2020
Extension 1 Granted
Mar 3, 2020
Extension 1 Filed
Mar 3, 2020
Teas Extension Received
Sep 3, 2019
Noa E-Mailed - Sou Required From Applicant
Aug 14, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 14, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 9, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 9, 2019
Published For Opposition
Jun 19, 2019
Notification Of Notice Of Publication E-Mailed
May 30, 2019
Assigned To Lie
May 15, 2019
Approved For Pub - Principal Register
May 15, 2019
Examiner's Amendment Entered
May 15, 2019
Notification Of Examiners Amendment E-Mailed
May 15, 2019
Examiners Amendment E-Mailed
May 15, 2019
Examiners Amendment -Written
May 8, 2019
Notification Of Priority Action E-Mailed
May 8, 2019
Priority Action E-Mailed
May 8, 2019
Priority Action Written
May 1, 2019
Assigned To Examiner
Apr 25, 2019
Notice Of Design Search Code E-Mailed
Apr 23, 2019
New Application Office Supplied Data Entered In Tram
Apr 9, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
